Ensemble learning-guided discovery of anti-tuberculosis phytochemicals: computational prediction and mechanistic insights
Clinical Snapshot
PICO Framework
| P — Population | Phytochemicals from natural products (4707 compounds screened) |
| I — Intervention | Ensemble machine learning models (ExtraTrees) with molecular docking analysis |
| C — Comparator | Validated anti-TB dataset of 425,180 compounds with known activity |
| O — Outcomes | Prediction of anti-TB activity, binding affinity to M. tuberculosis targets, multi-target engagement potential |
Bottom Line
This computational study presents a sophisticated approach to anti-TB drug discovery, combining ensemble machine learning with structure-based design to identify promising phytochemical candidates. The methodology is scientifically sound, achieving excellent predictive performance and identifying 778 high-confidence compounds with potential anti-TB activity. The multi-target docking analysis adds mechanistic depth, revealing 193 compounds with multi-target engagement potential. However, the study's impact is limited by its purely computational nature—experimental validation is essential before clinical relevance can be established. The work provides a valuable framework for prioritizing natural products for TB drug development, particularly important given rising drug resistance. Australian researchers and clinicians should view this as a promising lead generation tool rather than immediate therapeutic guidance. The identified compounds require extensive medicinal chemistry optimization, toxicity assessment, and preclinical validation before any clinical consideration.
Key Findings
P Value: Not applicable for computational study
Effect Size: 3209 predicted actives (68.2% hit rate) with 778 meeting applicability domain criteria
Primary Outcome: Identification of 778 high-confidence anti-TB phytochemical candidates from 4707 screened compounds
Nnt Or Sensitivity: ROC-AUC: 0.983, Matthews Correlation Coefficient: 0.871, 486 compounds with favorable binding affinities
Confidence Interval: Not applicable for computational predictions
Clinical Application
Requires experimental validation and medicinal chemistry optimization before clinical application Highly relevant given Australia's TB burden in Indigenous communities and immigrant populations; aligns with TGA's interest in natural product-derived therapeutics Patients with drug-susceptible and drug-resistant tuberculosis globally
Abstract
Tuberculosis (TB) remains a major global health challenge driven by persistent Mycobacterium tuberculosis infection and increasing drug resistance. Phytochemicals represent a structurally diverse and underexplored chemical space for anti-TB drug discovery, yet systematic prioritization strategies integrating machine learning and structure-based validation are limited. A curated phenotypic anti-TB dataset of 425,180 compounds was used to train ensemble ExtraTrees models based on ECFP4 fingerprints and physicochemical descriptors. The models achieved strong predictive performance (ROC-AUC up to 0.983; MCC up to 0.871). SHAP analysis enabled mechanistic interpretation by identifying the key molecular descriptors and fingerprint features driving anti-TB activity predictions. The validated ensemble was applied to screen 4707 phytochemicals, yielding 3209 predicted actives, of which 778 satisfied applicability domain criteria. High-confidence candidates were subsequently evaluated by molecular docking against twelve structurally validated essential M. tuberculosis targets spanning cell wall biosynthesis, energy metabolism, nucleotide synthesis, and cofactor pathways. Docking analysis identified 486 phytochemicals with favorable predicted binding affinities, including 193 compounds exhibiting multi-target engagement. Several top-ranked candidates reproduced canonical interaction patterns of co-crystallized inhibitors, supporting mechanistic plausibility. This integrated chemoinformatics and structure-based framework enables robust prioritization of phytochemicals with biologically meaningful and multi-target antitubercular potential. The study provides a computationally grounded strategy for accelerating lead identification against drug-resistant TB.
References
- 1.Sajal, Harshit, Mohan, Aswin, Raju, Rajesh, & Nadh, Anuroopa G. (2026). Ensemble learning-guided discovery of anti-tuberculosis phytochemicals: computational prediction and mechanistic insights. Journal of Computer-Aided Molecular Design. https://doi.org/10.1126/sciadv.1500106
Related Research
Journal of medical Internet research
Advancing Human-Centered AI in Clinical Decision Support: Sociocognitive Human-in-the-Loop Study in HIV Care
2 Aug 2026
JBJS reviews
One-Stage or Two-Stage Revision for Infected Shoulder Arthroplasty: A Head-to-Head Meta-Analysis of Comparative Studies
30 July 2026
Signal transduction and targeted therapy
Mucosal immunity and vaccine development
27 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service